O

Orchard Therapeutics

188 employees

Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.

Basic info

Industry

biotechnology research

Sectors

Paediatric diseases
Biotechnology
Health Diagnostics
Health Care
Orphan diseases
Stem cell technology
Genetics
Gene therapy

Date founded

2015

Funding rounds raised

Total raised

$150M

from 25 investors over 25 rounds

O

Orchard Therapeutics raised $34M on March 6, 2023

Investors: RA Capital Management, L.P. and Woodline Partners LP

O

Orchard Therapeutics raised $150M on February 5, 2021

Investors: RA Capital Management, L.P., Farallon Capital Management, Avidity Partners, Casdin Capital, LLC and Surveyor Capital

O

Orchard Therapeutics raised $150M on August 13, 2018

Investors: RA Capital Management, L.P., Temasek, Foresite Capital, Venrock, RTW Investments, LP, Perceptive Advisors and Driehaus Capital Management LLC

O

Orchard Therapeutics raised $110M on December 20, 2017

Investors: UCL Technology Fund, F-Prime Capital Partners, Temasek, RTW Investments, LP, Agent Capital, Cowen Inc., Baillie Gifford and ORI Capital Limited

O

Orchard Therapeutics raised $31M on May 3, 2016

Investors: UCL Technology Fund, AlbionVC and F-Prime Capital Partners

FAQ